Shares of Calumet, Inc. (NASDAQ:CLMT – Get Free Report) have earned an average rating of “Hold” from the eight research firms that are currently covering the company, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and four have issued a buy recommendation on the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $20.0417.
A number of equities research analysts recently issued reports on CLMT shares. HC Wainwright restated a “buy” rating and issued a $33.00 price objective on shares of Calumet in a research note on Monday, November 10th. Zacks Research upgraded shares of Calumet from a “strong sell” rating to a “hold” rating in a research note on Thursday, November 6th. Wall Street Zen lowered shares of Calumet from a “buy” rating to a “hold” rating in a research report on Sunday, December 14th. TD Cowen upped their price target on shares of Calumet from $15.00 to $18.00 and gave the company a “hold” rating in a research note on Tuesday, November 11th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Calumet in a report on Monday, December 22nd.
View Our Latest Research Report on Calumet
Hedge Funds Weigh In On Calumet
Calumet Price Performance
NASDAQ:CLMT opened at $19.69 on Friday. The company has a market capitalization of $1.71 billion, a P/E ratio of -45.79 and a beta of 1.18. The business has a fifty day simple moving average of $19.43 and a two-hundred day simple moving average of $17.62. Calumet has a 1 year low of $7.68 and a 1 year high of $23.75.
Calumet (NASDAQ:CLMT – Get Free Report) last issued its quarterly earnings results on Friday, November 7th. The oil and gas company reported ($0.21) EPS for the quarter, beating analysts’ consensus estimates of ($0.30) by $0.09. The firm had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.06 billion. The firm’s quarterly revenue was down 2.0% on a year-over-year basis. During the same period in the prior year, the company earned ($1.18) EPS. As a group, analysts anticipate that Calumet will post -3.02 earnings per share for the current year.
About Calumet
Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.
Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.
Recommended Stories
- Five stocks we like better than Calumet
- Do not delete, read immediately
- How the Rich Retire
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- How Long Will $1M Last in Retirement?
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Calumet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet and related companies with MarketBeat.com's FREE daily email newsletter.
